Skip to main content
Market intelligence
ETONHealthcare

Eton Pharmaceuticals Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 6, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 6, 2026David KrempaChief Business OfficerSale4,166$55.07$229,406
Aug 28, 2026Paul V MaierCorporate insiderSale50,000$59.07$2,953,570
Aug 24, 2026David KrempaChief Business OfficerSale25,000$65.07$1,626,750